source
- Moderna's mRNA flu vaccine mFLUVISA receives FDA approval after earlier filing refusalThe U.S. Food and Drug Administration initially issued a refusal-to-file letter to Moderna's flu vaccine in February, but a few days later reversed that decision and accepted a revised submission f…
- BioNTech appoints former Sobi chief Guido Oelkers as new CEOBioNTech has filled its long-vacant chief executive position after a six-month search. The board selected Guido Oelkers, Ph.D., who most recently led Swedish pharmaceutical company Sobi. At Sobi,…